• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRICLIP¿ STEERABLE GUIDE CATHETER; TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRICLIP¿ STEERABLE GUIDE CATHETER; TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number TSGC0201
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 09/05/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
It is unknown if the device is returning for analysis.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported on (b)(6) 2025 that the patient presented with grade 4 functional tricuspid regurgitation (tr) for a triclip procedure.During the procedure, triclip steerable guide catheter and triclip were advanced in right atrium(ra).A thrombus was noticed on the wall of the ra.The triclip was removed from the anatomy.An aspiration attempt was made to remove thrombus from the anatomy.The thrombus was no longer visible in imaging and the procedure was continued as per the protocol.The mr was reduced to grade 3 post procedure.There was no clinically significant delay.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported thrombus.Based on available information, a cause for the reported thrombus could not be conclusively determined.The reported patient effect of thrombosis/thrombus, as listed in the triclip system instructions for use, is a known possible complication associated with triclip procedures.The reported serious injury/ illness/ impairment was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event or Problem Description
It was reported on (b)(6) 2025 that the patient presented with grade 4 functional tricuspid regurgitation (tr) for a triclip procedure.During the procedure, triclip steerable guide catheter and triclip were advanced in right atrium(ra).A thrombus was noticed on the wall of the ra.The triclip was removed from the anatomy.An aspiration attempt was made to remove thrombus from the anatomy.The thrombus was no longer visible in imaging and the procedure was continued as per the protocol.The mr was reduced to grade 3 post procedure.There was no clinically significant delay.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported thrombus.Based on available information, a cause for the reported thrombus could not be conclusively determined.The reported patient effect of thrombosis/thrombus, as listed in the triclip system instructions for use, is a known possible complication associated with triclip procedures.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event or Problem Description
It was reported on (b)(6) 2025 that the patient presented with grade 4 functional tricuspid regurgitation (tr) for a triclip procedure.During the procedure, triclip steerable guide catheter and triclip were advanced in right atrium(ra).A thrombus was noticed on the wall of the ra.The triclip was removed from the anatomy.An aspiration attempt was made to remove thrombus from the anatomy.The thrombus was no longer visible in imaging and the procedure was continued as per the protocol.The mr was reduced to grade 3 post procedure.There was no clinically significant delay.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRICLIP¿ STEERABLE GUIDE CATHETER
Common Device Name
TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23184365
Report Number2135147-2025-05541
Device Sequence Number9843796
Product Code DQY
UDI-Device Identifier05415067047748
UDI-Public(01)05415067047748(17)260805(10)50205R1022
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K241538
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 12/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/05/2026
Device Model NumberTSGC0201
Device Catalogue NumberTSGC0201
Device Lot Number50205R1022
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/05/2025
Supplement Date Received by Manufacturer10/06/2025
12/03/2025
Initial Report FDA Received Date09/30/2025
Supplement Report FDA Received Date10/15/2025
12/10/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/05/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
2 TRICLIPS.
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient Age78 YR
Patient SexFemale
Patient Weight62 KG
-
-